Praxis Precision Medicines (PRAX) saw its shares surge in the last session with trading volume being higher than average. The ...

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, ...

Shares of biopharmaceutical company Praxis Precision Medicines Inc. soared Thursday, boosted by the successful trial of a new ...

TD Cowen, Piper Sandler, Guggenheim Securities and Truist Securities are acting as joint book-running managers for the offering. The offering is subject to market and other customary closing ...

We recently published Market Downturn? Not for these 10 Stocks; 7 Jump to Record Highs. Praxis Precision Medicines, Inc.

Praxis Precision Medicines PRAX stock surged after Phase 3 trials for its essential tremor drug met endpoints, prompting TD ...

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the ...

USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, Oct. /CNW/ — USA News Group News Commentary – Biomarker-driven drug development accelerates across oncology ...

The latest announcement is out from Praxis Precision Medicines ( (PRAX) ). On October 16, 2025, Praxis Precision Medicines announced positive topline results from its Phase 3 Essential3 program for ...

HALIFAX, NS, Oct. 16, 2025 /CNW/ – Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the strategic acquisition of George King Bio-Medical, Inc.

The Cessna Citation M2 Gen2 with Garmin Autothrottles recently received certification from the Federal Aviation ...